0001555280-20-000322.txt : 20201125 0001555280-20-000322.hdr.sgml : 20201125 20201125164222 ACCESSION NUMBER: 0001555280-20-000322 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201125 FILED AS OF DATE: 20201125 DATE AS OF CHANGE: 20201125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PECK KRISTIN C CENTRAL INDEX KEY: 0001488267 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35797 FILM NUMBER: 201351240 MAIL ADDRESS: STREET 1: C/O ZOETIS INC. STREET 2: 100 CAMPUS DRIVE CITY: FLORHAM PARK STATE: NJ ZIP: 07940 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zoetis Inc. CENTRAL INDEX KEY: 0001555280 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 460696167 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-822-7000 MAIL ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 4 1 wf-form4_160634052477128.xml FORM 4 X0306 4 2020-11-25 0 0001555280 Zoetis Inc. ZTS 0001488267 PECK KRISTIN C C/O ZOETIS INC. 10 SYLVAN WAY PARSIPPANY NJ 07054 1 1 0 0 Chief Executive Officer Common Stock 2020-11-25 4 M 0 6500 30.89 A 38374 D Common Stock 2020-11-25 4 S 0 7125 161.12 D 31249 D Common Stock 2020-11-25 4 S 0 3375 162.32 D 27874 D Stock Option 2020-11-25 4 M 0 6500 0 D Common Stock 6500.0 274185 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2019. The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.81 to $161.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.86 to $162.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. 6,500 options granted March 4, 2014 at an exercise price of $30.89 per option. Each option vests on the third anniversary of the date of grant. Each option expires on the tenth anniversary of the date of grant. 63,036 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; and 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option. /s/ Katherine H. Walden, as Attorney-in-Fact 2020-11-25